Orchestra BioMed OBIO 深 沪
等待开盘 10-14 09:30:00 美东时间
5.72
-0.190
-3.21%
华盛通- 最 高5.87
- 今 开5.87
- 成交量 20.48万股
- 最 低 5.71
- 昨 收 5.91
- 总市值 3.44亿
- 52周最高 6.50
- 市盈率 静 --
- 换手率 0.34%
- 52周最低 3.46
- 委 比 -15.13%
- 总股本 6010.50万
- 历史最高 23.39
- 量 比 0.88
- 振 幅 2.71%
- 历史最低 2.20
- 每 手 1
- 风险率 0.66%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Orchestra BioMed Exceeds Full Enrollment Target in the BACKBEAT Global Pivotal Trial of AVIM Therapy
Orchestra BioMed announced the completion of enrollment in the BACKBEAT Trial, surpassing the target of 316 randomized patients with 330 participants across 13 countries. The trial evaluates AVIM Therapy for uncontrolled hypertension in pacemaker patients. Primary endpoint data is expected in Q2 2027 for potential late-breaking presentation and future FDA submissions. AVIM Therapy aims to lower blood pressure through atrioventricular interval mod...
10-01 12:00
美股大行评级 | 齐声看好医药股！礼来、强生、默沙东目标价均获上调；小摩大幅上调Meta目标价至820美元
今日重点评级关注：康托·菲茨杰拉德：维持SOL Strategies"超配"评级，目标价从2.8美元升至6.2美元；康托·菲茨杰拉德：维持Sui Group Holdings"超配"评级，目标价从1.7美元升至3.4美元
09-11 14:30
Wealthfront, Orchestra Biomed, AeroVironment And Other Big Stocks Moving Higher On Thursday
U.S. stocks were lower, with the Dow Jones index falling around 250 points on Thursday. Shares of Wealthfront Corp (NASDAQ:WLTH) rose sharply during Thursday’s session following better-than-expected second-quarter results. Wealthfront reported quarterly earnings of 10 cents per share which beat the ...
09-10 22:02
This Meta Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Keefe, Bruyette & Woods analyst Wood Lay upgraded Simmons First National Corp (NASDAQ:SFNC) from ...
09-10 20:53
BTIG Upgrades Orchestra BioMed Hldgs to Buy, Announces $10 Price Target
BTIG analyst Marie Thibault upgrades Orchestra BioMed Hldgs (NASDAQ:OBIO) from Neutral to Buy and announces $10 price target.
09-10 17:56
Orchestra BioMed Highlights Pivotal Cardiovascular Program Progress
An announcement from Orchestra BioMed Holdings ( ($OBIO) ) is now available. In...
09-08 21:54
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Orchestra BioMed Holdings, Inc. granted stock options to purchase 133,000 shares of its common stock to seven newly hired employees on September 1, 2026, under its 2025 New Hire Inducement Plan. The stock options will vest over a four-year period. The company, which accelerates high-impact biomedical technologies through partnerships with global medical device leaders, is currently developing two flagship products: AVIM Therapy for hypertension a...
09-02 20:05
美股牛股 | 医药股AMLX飙升63%，全球首创GLP-1R拮抗剂三期临床试验成功；WEAV劲升31%
医药股AMLX飙升63%，全球首创GLP-1R拮抗剂三期临床试验成功；WEAV劲升31%，获私募巨头溢价34%收购；CDNL升逾15%，高管近日增持320万美元股份>>
08-19 16:11
美股大行评级 | 潜在涨幅207.38%！Truist Securities上调AbCellera Biologics目标价至30美元，维持"买入"评级
今日重点评级关注：Truist Securities：维持AbCellera Biologics"买入"评级，目标价从12美元升至30美元；Stifel：维持Proficient Auto Logistics"买入"评级，目标价从9美元升至12美元
08-12 08:45
Piper Sandler Reiterates Overweight on Orchestra BioMed Hldgs, Raises Price Target to $10
Piper Sandler analyst Matt O'Brien reiterates Orchestra BioMed Hldgs (NASDAQ:OBIO) with a Overweight and raises the price target from $9 to $10.
08-11 21:16
